HOME >> BIOLOGY >> NEWS
MRI drug may improve cancer-killing ability of chemotherapy, study says

A contrast agent currently used in magnetic resonance imaging (MRI), called mangafodipir, may increase the cancer-killing ability of some chemotherapy drugs while protecting normal cells, according to a study in the February 15 issue of the Journal of the National Cancer Institute .

Many anticancer drugs work by increasing the levels of tumor cell hydrogen peroxide. Tumor cells are particularly sensitive to hydrogen peroxide and die as a result. However, certain enzymes in the body can work to protect cells from this kind of damage, rendering certain cancer drugs less effective. In addition, the drugs are toxic to normal cells. The drug mangafodipir, a contrast agent given to patients before they have an MRI, helps promote the production of hydrogen peroxide while at the same time, through different biologic mechanisms, protects healthy cells from the negative effects of oxidative damage.

Jrme Alexandre, M.D., of the Groupe hospitalier Cochin-Saint Vincent de Paul in Paris, and colleagues exposed tumor cells and white blood cells from 10 cancer patients and white blood cells from six control subjects to three chemotherapy drugs--paclitaxel, oxaliplatin, and 5-fluorouracil--in the presence or absence of mangafodipir. They also studied the effects of mangafodipir on colon cancer cells in mice treated with paclitaxel.

The authors found that mangafodipir protected the white blood cells taken from healthy volunteers and from cancer patients. The drug also protected paclitaxel-treated mice from infection that would cause a lowered white blood cell count and helped increase the cancer cell-killing ability of the chemotherapy drug paclitaxel against the cancer cells in mice.

"Our results support investigation of the use of mangafodipir in cancer patients, because mangafodipir may enhance the therapeutic index of anticancer agents by both protecting normal cells and increasing antitumoral activity of these agents," the authors wri
'"/>

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
14-Feb-2006


Page: 1 2

Related biology news :

1. New test improves detection of liver cancer
2. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
3. Gene expression pattern could lead to improved treatment of pediatric septic shock
4. Additional mammogram readers improve breast cancer detection
5. New role for protein in fat cells may improve understanding of obesity and diabetes
6. Jefferson scientists patent dramatically improves
7. Cardiac patches stimulate regeneration, improve function after heart attack
8. Co-operation between GSF and clinic improves outlook for sarcoma patients
9. EPA foregoes opportunity to improve nanotechnology oversight
10. Biocontrol of invasive water hyacinth contributes to socioeconomic and health improvements in Africa
11. Kansas, Missouri School Board members to explore improvements in science-related education

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... (PRWEB) , ... August 05, 2019 , ... ... technology, is pleased to announce its attendance at the Microscopy & Microanalysis 2019 ... Portland, Oregon at the Oregon Convention Center. , The Microscopy & Microanalysis Meeting, ...
(Date:8/1/2019)... ... 2019 , ... John R. Freeman, CPA, has joined BioLabs as Chief Financial ... BioLabs, which provides premier co-working spaces for life science startups in the most dynamic ... and manage growth,” says Fruehauf. “BioLabs has expanded to 10 locations in just a ...
(Date:7/26/2019)... ANGELES (PRWEB) , ... July 26, 2019 , ... ... to announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps to ... trauma. , Helius Medical Technologies is a neurotech company in the ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... (PRWEB) , ... July 02, 2019 , ... Leading Regenerative ... entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on regenerative veterinary ... animals. Animal Pharm was recently included in the Brentwood and Pacific ...
(Date:6/12/2019)... ... June 12, 2019 , ... Leak ... instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is excited ... The agreement will grant exclusive rights for Zillion to represent LDA in all ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... engagement, and Carilion Clinic, a national leader in opioid treatment, announced today they ... care. , Mytonomy recently deployed its virtual care platform at the ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary ... of cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of ... cells with engineered T cell receptors known as “CARs”. The CAR enables the final ...
Breaking Biology Technology:
Cached News: